Decision Resources, Inc., Feb 2010, Pages: 32
The hottest field in antivirals is hepatitis C virus (HCV) drug development; compounds against novel HCV targets such as NS3/4A protease, NS5B polymerase, and NS5A hold the promise
BioPharm Reports (VennBio Ltd.), Jan 2009, Pages: 235
includes proposed resistance mechanisms associated with CSCs, drugdiscovery strategies for the targeting of these cells, the current CSC-targetingdrug development pipeline and the potential of these cells
Bioseeker, June 2010, Pages: 596
125 identified targets of peptide drugs, organized into 103 drugtarget strategies, and assesses them in 52 different cancer indications.
The discovery of new cancer therapeutics has seen a significant
Bioseeker, Dec 2011, Pages: 1617
.2.52 Ubiquitin-specific Protease Activity Targets
6.2.53 Other Targets
6.3 The Cancer Genome Project and Targets of Apoptotic Drugs in Oncology
6.3.1 Targets of Apoptotic Drugs in Oncology Present
Business Insights, Aug 2006, Pages: 156
‘omics technologies
Uses of metabolomics in drugdiscovery and development
Advantages of metabolomics
Challenges to the field of metabolomics
Conclusions
Chapter 2 Platform technologies
Jain PharmaBiotech, Feb 2012, Pages: 481
efflux
Antiviral hyperactivation-limiting therapeutics
Blocking of HIV budding by DC-SIGN protein
ATR kinase as a target for anti-HIV drugdiscovery
Nanoviricides for HIV/AIDS
Prophylactic measures
Bioseeker, June 2010, Pages: 838
202 identified targets of prostate cancer drugs, organized into 187 drugtarget strategies, and assesses them in prostate cancer. Significantly new prostate cancer therapies will soon come to challenge
MP Advisors, Jan 2011, Pages: 150
on innovative biologics/ drugs along with a detailed assessment of technology platforms and IP potential.
Mature Biotech (MB):
MP Advisors' defines Mature Biotech (MB) companies as those which have reached
Biophoenix Limited, Feb 2009, Pages: 312
, at least partly and/or indirectly, via apoptosis modulation. In cancer and in other diseases, elements of the apoptotic process become dysregulated, offering many direct targets for drugdiscovery
GlobalData, Sep 2011, Pages: 40
03, 2011: Discovery Laboratories Reports Q2 2011 Results
Jun 22, 2011: Discovery Labs' Aerosol Drug Delivery Technology Showcased At International Society For Aerosols In Medicine Annual Meeting
May
John Wiley and Sons Ltd, Oct 2011, Pages: 390
looks at new targets and opportunities, discussing several drugtargets and diseases for which peptide drugs are currently being developed. Preface
List of Contributors
Part I The Academia
Bioseeker, May 2009, Pages: 362
The discovery of new cancer therapeutics has seen a significant shift towards biologicals as an alternative to small molecule drugs. Alternative binding peptide molecules, derived from combinatorial
Decision Resources, Inc., Dec 2009, Pages: 38
the insights we garnered from our survey of more than 200 U.S. medical oncologists about targeted therapies, existing unmet needs, and future opportunities in this arena.
Questions Answered in This Report
BioPharm Reports (VennBio Ltd.), Feb 2008, Pages: 178
mechanistic level is a fundamental consideration and new drugs must target bacterial pathogens in new ways, compared with many long-established antibiotics. A new drugdiscovery era is emerging, based
Business Insights, Oct 2004 targets in the treatment of diseases such as cancer and Alzheimer's. Use this report to identify the most important technologies, their applications in drugdiscovery and clinical trial design
Global Markets Direct, Nov 2011, Pages: 41
. in its therapy areas of focus.
- Identify new drugtargets and therapeutic classes in the Medisyn Technologies, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those
Jain PharmaBiotech, Feb 2012, Pages: 1029
9. Molecular Diagnostics in Biopharmaceutical Industry & Healthcare
Introduction
Molecular diagnostics in biopharmaceutical industry
Molecular diagnostic technologies and drugdiscovery
Molecular
